Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019

被引:0
|
作者
Liu, Zhi-Peng [1 ]
Ouyang, Guo-Qing [1 ]
Huang, Guo-Zhen [1 ]
Wei, Jie [1 ]
Dai, Luo [1 ]
He, Song-Qing [1 ]
Yuan, Guan-Dou [1 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
基金
中国国家自然科学基金;
关键词
Cirrhosis; Nonalcoholic fatty liver disease; Global burden of disease; Prevalence; Disability-adjusted life years; Death; PREVALENCE; FIBROSIS; MORTALITY; RISK;
D O I
10.4254/wjh.v15.i11.1210
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDNonalcoholic fatty liver disease (NAFLD) has become the leading cause of cirrhosis and other chronic liver diseases (COCLDs).AIMTo conduct a comprehensive and comparable updated analysis of the global, regional, and national burden of COCLDs due to NAFLD in 204 countries and territories from 1990 and 2019 by age, sex, and sociodemographic index.METHODSData on COCLDs due to NAFLD were collected from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. Numbers and age-standardized prevalence, death, and disability-adjusted life years (DALYs) were estimated through a systematic analysis of modelled data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. The estimated annual percentage change was used to determine the burden trend.RESULTS In 2019, the global age-standardized prevalence rate of COCLDs due to NAFLD was 15022.90 per 100000 population [95% uncertainty interval (UI): 13493.19-16764.24], which increased by 24.51% (22.63% to 26.08%) from 1990, with an estimated annual percentage change of 0.78 (95% confidence interval: 0.74-0.82). In the same year, however, the age-standardized death rate and age-standardized DALYs per 100000 population were 1.66 (95%UI: 1.20-2.17) and 43.69 (95%UI: 31.28-58.38), respectively. North Africa and the Middle East had the highest prevalence rates of COCLDs due to NAFLD. The death rate increased with age up to the 95+ age group for both sexes. Males had higher numbers of prevalence, death rate, and DALYs than females across all age groups before the 65-69 age group. The sociodemographic index was negatively correlated with the age-standardized DALYs.CONCLUSIONGlobally, the age-standardized prevalence rate has increased during the past three decades. However, the age-standardized death rate and age-standardized DALYs decreased. There is geographical variation in the burden of COCLDs due to NAFLD. It is strongly recommended to improve the data quality of COCLDs due to NAFLD across all countries and regions to facilitate better monitoring of the burden of COCLDs due to NAFLD.
引用
收藏
页码:1210 / 1225
页数:16
相关论文
共 50 条
  • [31] A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
    Caussy, Cyrielle
    Tripathi, Anupriya
    Humphrey, Greg
    Bassirian, Shirin
    Singh, Seema
    Faulkner, Claire
    Bettencourt, Ricki
    Rizo, Emily
    Richards, Lisa
    Xu, Zhenjiang Z.
    Downes, Michael R.
    Evans, Ronald M.
    Brenner, David A.
    Sirlin, Claude B.
    Knight, Rob
    Loomba, Rohit
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [32] A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
    Cyrielle Caussy
    Anupriya Tripathi
    Greg Humphrey
    Shirin Bassirian
    Seema Singh
    Claire Faulkner
    Ricki Bettencourt
    Emily Rizo
    Lisa Richards
    Zhenjiang Z. Xu
    Michael R. Downes
    Ronald M. Evans
    David A. Brenner
    Claude B. Sirlin
    Rob Knight
    Rohit Loomba
    Nature Communications, 10
  • [33] Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990-2019
    Ghamari, Seyyed-Hadi
    Yoosefi, Moein
    Abbasi-Kangevari, Mohsen
    Malekpour, Mohammad-Reza
    Moghaddam, Sahar Saeedi
    Shahin, Sarvenaz
    Esfahani, Zahra
    Koolaji, Sogol
    Shobeiri, Parnian
    Ghaffari, Aydin
    Sohrabi, Hanye
    Kazemi, Ameneh
    Rezaei, Negar
    Larijani, Bagher
    Farzadfar, Farshad
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1764 - 1775
  • [34] The burden of chronic kidney disease in Asia, 1990-2019: Examination of estimates from global burden of disease 2019 study
    Aashima
    Nanda, Mehak
    Sharma, Rajesh
    Jani, Chinmay
    NEPHROLOGY, 2022, 27 (07) : 610 - 620
  • [35] Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2019
    Li, Xue
    Feng, Xiaojin
    Sun, Xiaodong
    Hou, Ningning
    Han, Fang
    Liu, Yongping
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [36] The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: A systematic analysis for the global burden of disease study 2019
    Park, Jihye
    Jeong, Gwang Hun
    Song, Minjin
    Yon, Dong Keon
    Lee, Seung Won
    Koyanagi, Ai
    Jacob, Louis
    Kostev, Karel
    Dragioti, Elena
    Radua, Joaquim
    Cheon, Jae Hee
    Shin, Jae Il
    Smith, Lee
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (10) : 1352 - 1359
  • [37] Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019
    Jeong, Yeon Jae
    Park, Seoyeon
    Yon, Dong Keon
    Lee, Seung Won
    Tizaoui, Kalthoum
    Koyanagi, Ai
    Jacob, Louis
    Kostev, Karel
    Dragioti, Elena
    Radua, Joaquim
    Stickley, Andrew
    Oh, Hans
    Shin, Jae Il
    Smith, Lee
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (04)
  • [38] Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases
    Riley, TR
    Bruno, MA
    JOURNAL OF CLINICAL ULTRASOUND, 2005, 33 (09) : 439 - 441
  • [39] Diabetes therapy in nonalcoholic fatty liver disease and liver cirrhosis
    Bojunga, Joerg
    GASTROENTEROLOGE, 2020, 15 (02): : 96 - 105
  • [40] Nonalcoholic fatty liver disease and risk of cirrhosis
    Padoin, Alexandre Vontobel
    Staub, Henrique Luiz
    Chatkin, Jose Miguel
    Moretto, Myriam
    Maggioni, Lucas
    Rizzolli, Jacqueline
    Mottin, Claudio Cora
    SCIENTIA MEDICA, 2008, 18 (04) : 172 - 176